Clinical Trials

KATHERINE - Breast Cancer Study (H-32879)

Women with HER-2 positive breast cancer that have completed their preoperative treatment are invited to participate in a clinical trial using "Kadcyla" (also known as, TDM-1 or Trastuzumab Emtansine) versus "Herceptin" (Trastuzumab). Please contact Dorothy Williams at (713) 798-1943 or or Afife Batarse at (713) 798-1911 or for more information.

For study details see A Study of Trastuzumab Emtansine Versus Trastuzumab as Adjuvant Therapy in Patients With HER2-Positive Breast Cancer Who Have Residual Tumor in the Breast or Axillary Lymph Nodes Following Preoperative Therapy (KATHERINE).